# US 6,730,629 B2 · Asymmetric phosphine ligand

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 6,730,629 B2
- Document ID: US6730629B2
- Status: Granted
- Kind: B2
- Application number: 10/315,255
- Filed: 2002-12-10
- Published: 2003-07-24
- Granted: 2004-05-04
- Earliest claimed: 2001-12-10
- Assignees: Takasago International Corporation
- Inventors: Kazuhiko Matsumura; Takao Saito
- Web page: https://patentgrep.com/patent/US6730629B2

## CPC

- C07F 15/04: Nickel compounds
- B01J 31/2295: {Cyclic compounds, e.g. cyclopentadienyls}
- B01J 31/2433: {comprising aliphatic or saturated rings}
- B01J 31/2476: {comprising aliphatic or saturated rings}
- C07B 53/00: Asymmetric syntheses
- C07C 231/18: by stereospecific synthesis
- C07F 9/5027: {Polyphosphines}
- C07F 9/65683: {the ring phosphorus atom being part of a phosphine}
- B01J 2231/645: of C=C or C-C triple bonds
- B01J 2531/821: Ruthenium
- B01J 2531/822: Rhodium
- B01J 2531/824: Palladium
- B01J 2531/827: Iridium
- B01J 2531/847: Nickel
- C07B 2200/07: Optical isomers
- C07F: ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM (metal-containing porphyrins C07D487/22)
- B01J: CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- C07B: GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR (preparation of carboxylic acid esters by telomerisation C07C67/47; telomerisation C08F)
- C07C: ACYCLIC OR CARBOCYCLIC COMPOUNDS

## Abstract

A phosphine compound having excellent properties (chemical selectivity, enantioselectivity, catalytic activity) as a catalyst for asymmetric syntheses, especially asymmetric hydrogenations. A phosphine-phospholane compound represented by the following formula (1): a phosphine-primary phosphine intermediate; a transition metal complex including the phosphine-phospholane compound of formula (1) and a transition metal, and a catalyst including the transition metal complex.

## Claims

### Claim 1

A phosphine-phospholane compound represented by the formula (1):
wherein R1 represents hydrogen atom, a linear or branched alkyl group having 1 to 4 carbon atoms; R2 represents hydrogen atom or OR21, where R21 represents an alkyl group having 1 to 4 carbon atoms, a represents an integer of 1 to 2, b represents an integer of 1 to 3, the sum of a and b is 2 or 3, provided that at least one of R1 and R2 is not a hydrogen atom; R3, R4, R5 and R6 are the same or different, and each represents hydrogen atom, an alkyl group having 1 to 6 carbon atoms, or an alkoxy group having 1 to 6 carbon atoms, and each of (1) R3 and R4, (2) R4 and R5, and (3) R5 and R6 may be combined to form a ring which may contain one or more oxygen atoms; and R7 and R8 are the same or different, and each represents (1) a linear or branched alkyl group having 1 to 6 carbon atoms, (2) a cycloalkyl group having 3 to 7 carbon atoms, (3) a perfluoroalkyl group, (4) a phenyl group, (5) a phenyl group having one or more substituents each selected from the group consisting of an alkyl group having 1 to 6 carbon atoms, an alkyl group having 1 to 6 carbon atoms which is substituted by one or more halogen atoms, an alkoxy group having 1 to 6 carbon atoms, and a halogen atom, (6) an aralkyl group having 7 to 12 carbon atoms, or (7) a ring-substituted aralkyl group.

### Claim 2

A tertiary phosphine-primary phosphine compound represented by the formula (2):
wherein R1 represents hydrogen atom, a linear or branched alkyl group having 1 to 4 carbon atoms; R2 represents hydrogen atom or OR21, where R21 represents an alkyl group having 1 to 4 carbon atoms, a represents an integer of 1 to 2, b represents an integer of 1 to 3, the sum of a and b is 2 or 3, provided that at least one of R1 and R2 is not a hydrogen atom; R3, R4, R5 and R6 are the same or different, and each represents hydrogen atom, an alkyl group having 1 to 6 carbon atoms, or an alkoxy group having 1 to 6 carbon atoms, and each of (1) R3 and R4, (2) R4 and R5, and (3) R5 and R6 may be combined to form a ring which may contain one or more oxygen atoms.

### Claim 3 (depends on 1)

A transition metal complex comprising the phosphine-phospholane compound represented by the formula (1) of claim 1 and a transition metal, wherein the transition metal is selected from the group consisting of Ir, Rh, Ru, Pd, and Ni.

### Claim 4 (depends on 3)

A catalyst for asymmetric syntheses, which comprises the transition metal complex according to claim 3.

### Claim 5 (depends on 1, 4)

The catalyst for asymmetric synthetic reactions according to claim 4, wherein the transition metal complex is represented by the formula (3):
MmLnXpYq (3)
wherein M is a transition metal selected from the group consisting of Ir, Rh, Ru, Pd, and Ni and L represents the phosphine-phospholane compound represented by the general formula (1) of claim 1; and
when M is Ir or Rh, X is Cl, Br, or I, and m=n=p=2 and q=0;
when M is Ru, (i) X is Cl, Br, or I, Y represents a trialkylamino group, and m=n=2, p=4 and q=1, (ii) X is Cl, Br, or I, Y represents pyridyl group or a ring-substituted pyridyl group, and m=n=1, p=2, and q=2, (iii) X is a carboxylate group, and m=n=1, p=2 and q=0, or (iv) X is Cl, Br, or I, and m=n=p=2 and q=0;
when M is Pd, (i) X is Cl, Br, or I, and m=n=1, p=2, and q=0 or (ii) X is an allyl group, and m=n=p=2 and q=0; and
when M is Ni, X is Cl, Br, or I, and m=n=1, p=2, and q=0.

### Claim 6 (depends on 1, 4)

The catalyst for asymmetric synthetic reaction according to claim 4, wherein the transition metal complex is represented by the formula (4):
[MmLnXpYq]Zs (4)
wherein M is a transition metal selected from the group consisting of Ir, Rh, Ru, Pd, and Ni and L represents the phosphine-phospholane compound represented by the general formula (1) of claim 1; and
when M is Ir or Rh, (i) X is 1,5-cyclooctadiene or norbornadiene, Z is BF4, ClO4, OTf, PF6, SbF6, or BPh4, and m=n=p=s=1 and q=0 or (ii) Z is BF4, ClO4, OTf, PF6, SbF6, or BPh4, and m=s=1, n=2 and q=0;
when M is Ru, (i) X is Cl, Br, or I, Y represents an aromatic compound or olefin compound which is a neutral ligand, Z is Cl, Br, I, I3, or a sulfonate, and m=n=p=s=q=1 or (ii) Z is BF4, ClO4, OTf, PF6, SbF6, or BPh4, and m=n=1, p=q=0, and s=2 or (iii) X is Cl, Br, or I, Z is Me2NH2 or Et2NH2, and m=n=2, p=5, q=0, s=1; and
when M is Pd or Ni, Z is BF4, ClO4, OTf, PF6, SbF6, or BPh4, and m=n=1, p=q=0, and s=2,
where Ph represents a phenyl group and Tf represents a triflate group (SO2CF3).

### Claim 7 (depends on 3)

A catalyst for asymmetric hydrogenation, which comprises the transition metal complex according to claim 3.

### Claim 8 (depends on 4)

The catalyst according to claim 4, wherein the catalyst is a catalyst for an asymmetric hydrogenation.
